3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
3
Sarcoma
2
Meningioma
2
Brain Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Resectable Lung Non-Small Cell Carcinoma
1
Pituitary Neoplasms
1
Pancreatic Neoplasms
1
Neurilemmoma
1
Nerve Sheath Neoplasms
1
Neoplasms
1
Ion Beam Radiation Therapy for Tumor Patients
1
Gastroesophageal Junction Adenocarcinoma
1
Clinical Stage I Esophageal Adenocarcinoma AJCC v8
1
Carcinoma, Adenoid Cystic
1
Breast Neoplasms
1
Interventions
Gemcitabine
54
130-nm albumin-bound paclitaxel
29
Magnetic Resonance Spectroscopy
21
Taxes
18
Fluorouracil
18
Specimen Handling
17
Oxaliplatin
17
Leucovorin
17
Drug Therapy
17
Albumin-Bound Paclitaxel
17
Irinotecan
14
pembrolizumab
13
Cyclophosphamide
11
Blood Specimen Collection
11
Biopsy
11
fludarabine
10
Radiosurgery
9
irinotecan sucrosofate
8
folfirinox
6
Magnetic Resonance Imaging
6
Cetuximab
6
Bevacizumab
6
dehydroftorafur
5
Surveys and Questionnaires
5
Nivolumab
5
Endoscopic Ultrasound-Guided Fine Needle Aspiration
5
sintilimab
4
olaparib
4
balstilimab
4
Surgical Procedures, Operative
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Pancreatic Neoplasms
×
Protons
×
Clear all
NCT04894643
2026-03-20
PARC
EBG MedAustron GmbH
Phase NA
Recruiting
10 enrolled